Sharechat Logo

BLT - New Chief Executive Appointed

Tuesday 28th November 2023

Text too small?

Blis Technologies Limited (NZX: BLT ) has today announced the appointment of Scott Johnson as Chief Executive. Scott will replace Brian Watson, who announced his resignation in July 2023. Scott will take up the position of CEO effective from 15th January 2024.

 

Scott is highly experienced with effective leadership and management roles across local and international markets. He has direct industry experience in his previous role as Group Chief Executive of The Better Health Company Group, which is known for its Go Healthy consumer brand amongst others.

 

Geoff Plunket, Blis Technologies Chair, said “We are extremely pleased to welcome Scott to Blis Technologies as CEO. He has a proven track record for building business capability to deliver profitable growth into global markets. His breadth of experience across sales, marketing and operations will be invaluable in delivering Blis’ growth aspirations.”

 

Ends

 

For further information, please contact:

 

Geoff Plunket

Chair

+64 21 229 8886

 

About Blis Technologies Ltd

 

Delivering proven health benefits through evidence-based, advanced probiotics

Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz.



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report